Efficacy of transplantation of combination of noncultured dermal and epidermal cell suspension vs epidermal ell suspension alone in vitiligo: A randomized clinical trial. Treatment outcomes of topical calcineurin inhibitor therapy for patients with vitiligo: A systematic review and meta-analysis. Phototherapy for vitiligo: A systematic review and meta-analysis.
Journal of the American Academy of Dermatology. In: Treatment of Skin Disease: Comprehensive Therapeutic Strategies. Vitiligo: Pathogenesis, clinical features, and diagnosis. But treatment might stop or slow the discoloring process and return some color to your skin. See your health care provider if areas of your skin, hair or mucous membranes lose coloring. Occasionally, the skin gets its color back. In most cases, pigment loss spreads and eventually involves most of the skin. Sometimes the patches stop forming without treatment. It's difficult to predict how this disease will progress. With this type, called acrofacial vitiligo, the affected skin is on the face and hands, and around body openings, such as the eyes, nose and ears. This type is called localized (focal) vitiligo. This type, called segmental vitiligo, tends to occur at a younger age, progress for a year or two, then stop. With this most common type, called generalized vitiligo, the discolored patches often progress similarly on corresponding body parts (symmetrically). With this type, called universal vitiligo, the discoloration affects nearly all skin surfaces. Vitiligo can start at any age, but usually appears before age 30.ĭepending on the type of vitiligo you have, it may affect: Loss of color in the tissues that line the inside of the mouth and nose (mucous membranes).Premature whitening or graying of the hair on your scalp, eyelashes, eyebrows or beard.Patchy loss of skin color, which usually first appears on the hands, face, and areas around body openings and the genitals.
0 kommentar(er)
